Drotaverine 80 mg & Mefenamic Acid 250 mg Tablet
Drotaverine 80 mg & Mefenamic Acid 250 mg Tablet

Drotaverine 80 mg & Mefenamic Acid 250 mg Tablet

Buyer Feedback
Price:680 INR
Minimum Order Quantity:10 Boxes
Posted by : Mr Satish Rana
Last updated on : Apr 16,2018
Product added on : Apr 13,2018
Product Code : DROVEN-MF
Send Inquiry Have a question?   Ask Supplier
Product Specifications
IngredientsDrotaverine 80 mg & Mefenamic Acid 250 mg
Trade Information
Main Domestic MarketAll India
Product Description
Being a quality focused organization, we are involved in making and supplying a range of tablets under the category of anti-inflammatory containing Drotaverine 80 mg & Mefenamic Acid 250 mg Tablets under brand name, DROVEN-MF in Ambala Cantt, Haryana, India. These tablets Being offered to reputed vendors to ensure the authenticity of the tablets offered by us.

Composition:Drotaverine 80 mg & Mefenamic Acid 250 mg.

Packing: 10x10 Blister.
About the Supplier

Established in 2016, VENISTRO BIOTECH has been a leading name in offering top notch Pain Relief Drugs & Medicines. Located in Ambala Cantt, Haryana, we offer the best quality Drotaverine 80 mg & Mefenamic Acid 250 mg Tablet to our customers at best prices in the industry.

  • Nature of Business
    Manufacturer / Supplier / Trading Company
  • Number of Employees
  • Year of Establishment
  • Annual Turnover
    Rs 2 Crores
  • Working Days
    Monday - Sunday
Send your inquiry directly to this supplierReceiver's Company Name: VENISTRO BIOTECH

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.

Send this inquiry to other Suppliers of similar products (?)
I agree to abide by all the Terms and Conditions of tradeindia.com
More Products By This Supplier
Venfresh Mouth Wash
62.50 INR / Milliliter/
Contact Details
#1, Gaurav Park, Above JD Sarees, Near rama filling station,
Ambala Cantt, Haryana, 133001, India
Contact Supplier
Mr Satish Rana
Mr Satish RanaSenior Manager
Last updated on : 07 December 2018 Report Incorrect Contact